← Leaderboards
Deanna A Kulpa
Emory University
$10,394,989
Attributed
$27,284,968
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2018–25$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$27,284,968 · 2
By mechanism
UM1$25,334,968 · 1
R01$1,950,000 · 1
Top collaborators
- Mirko Paiardini5 shared
- Guido Silvestri5 shared
Most similar at Emory University
Same institution · by research overlap
- Siddappa N Byrareddy$14,019,085
- Francois J Villinger$61,853,654
- Ann M Chahroudi$35,857,595
- Guido Silvestri$61,186,493
- Jeremy M. Boss$41,716,661
Others in their field
Other Emerging Leaders on “Virus Replication”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Timothy M Willson · University Of Cape Town$12,760,250
- Jacob D Estes · Oregon Health & Science University$11,577,664
- Wilton B Williams · Duke University$10,993,477
- Nilu Goonetilleke · Univ Of North Carolina Chapel Hill$10,203,419
- Priyamvada Acharya · Duke University$8,088,904
Research focus
Virus ReplicationVirusHiv InfectionsMaintenanceViralViremiaCytotoxic T-LymphocytesGenetic TranscriptionInnovationIn VivoMolecularNovel StrategiesViral ReboundViral ReservoirAntiretroviral TherapyCd8-Positive T-LymphocytesExcisionCellsAnimalsInfectionInterruptionInterleukin-15MediatingBase
Grant awards (10)
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,663,729
UM1 · FY2025 · AI
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,667,081
UM1 · FY2024 · AI
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$5,636,888
UM1 · FY2023 · AI
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$5,412,341
UM1 · FY2022 · AI
CD8 T cell suppression of HIV latency establishment and maintenance in virally suppressed individuals$390,000
R01 · FY2022 · AI · contact PI
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)$4,954,929
UM1 · FY2021 · AI
CD8 T cell suppression of HIV latency establishment and maintenance in virally suppressed individuals$390,000
R01 · FY2021 · AI · contact PI
CD8 T cell suppression of HIV latency establishment and maintenance in virally suppressed individuals$390,000
R01 · FY2020 · AI · contact PI
CD8 T cell suppression of HIV latency establishment and maintenance in virally suppressed individuals$390,000
R01 · FY2019 · AI · contact PI
CD8 T cell suppression of HIV latency establishment and maintenance in virally suppressed individuals$390,000
R01 · FY2018 · AI · contact PI